Lopinavir/ritonavir (Kaletra)

DRUG5 trials

Sponsors

Abbott

Conditions

HIV-1 InfectionsHuman Immunodeficiency VirusHuman Immunodeficiency Virus-Infection

Unknown Phase

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

CompletedNCT01074931

AbbottHIV-1 Infections

Start: 2008-04-30End: 2010-06-30Updated: 2011-08-03

Special Investigation of Kaletra in Pregnant Women

CompletedNCT01076985

AbbottHuman Immunodeficiency Virus

Start: 2000-12-31End: 2010-12-31Updated: 2012-01-18

Drug Use Investigation of Kaletra

CompletedNCT01076972

AbbottHuman Immunodeficiency Virus

Start: 2000-12-31End: 2010-12-31Updated: 2012-03-01

Evaluation of Kaletra Therapy Over the Long-term

CompletedNCT01083810

AbbottHuman Immunodeficiency Virus

Start: 2001-06-30End: 2010-06-30Updated: 2011-08-11

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

CompletedNCT01153269

AbbottHuman Immunodeficiency Virus-Infection

Start: 2001-05-31End: 2010-11-30Updated: 2011-12-19